ArticleCell communication and signaling : CCS2022

RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway.

Zhiqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.